AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
AstraZeneca's AI Agent Bet Points to a New Model for Drug Discovery Automation
AstraZeneca is reportedly turning to an AI agent to reduce the time needed for drug discovery. The move suggests the industry is starting to shift from passive prediction tools to more autonomous systems that can plan, search, and iterate across discovery workflows.
Owkin and AstraZeneca Expand Their AI Research Partnership as Pharma Bets on Smarter Discovery
Owkin and AstraZeneca are expanding collaboration on AI-driven drug research tools, adding another example of big pharma leaning into AI partnerships rather than trying to build everything in-house. The move suggests the market is maturing toward a hybrid model of internal science and external AI capabilities.
AstraZeneca CEO says AI will be central to cancer detection
AstraZeneca’s CEO is publicly framing AI as a key technology for future cancer detection, reflecting how major life sciences leaders increasingly see AI as strategic infrastructure rather than a side experiment. The statement also signals that drugmakers are watching the diagnostic side of oncology as closely as the therapeutic side.
AstraZeneca and Telangana Government Launch AI-Powered Lung Cancer Screening in Public Hospitals
AstraZeneca and Telangana are rolling out AI-powered lung cancer screening in public hospitals. The partnership suggests AI screening is increasingly being tested not just in premium health systems, but in public-sector care delivery.
AstraZeneca and Telangana Join Forces on AI-Enabled Lung Cancer Screening
AstraZeneca has signed an agreement with Telangana to introduce AI-based lung cancer screening, expanding the company’s public-sector partnerships in cancer detection. The deal reflects growing interest in using AI to bring screening infrastructure to regions where early diagnosis remains uneven.
AstraZeneca and Telangana Partner on AI-Powered Lung Cancer Screening
AstraZeneca’s agreement with Telangana to bring AI-enabled lung cancer screening into public hospitals is one of the clearest signs that oncology AI is moving into health-system infrastructure. The pilot could become a blueprint for public-private adoption in resource-constrained settings.
AI-Native Trial Platform Evinova Expands With AstraZeneca and Astellas Deals
Evinova, the digital health company launched by AstraZeneca, has added Astellas and AstraZeneca partnerships to deploy its AI-native platform for clinical development. The story is important because it highlights a quieter but commercially important healthcare AI trend: using AI to improve trial design, execution, and operational efficiency rather than only molecule discovery or front-line diagnosis.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.